| Eos ≤ 2% (n=74) | Eos > 2% (n=16) | p-value |
FEV1 %pred | 42.2±18.1 | 49.8±15.7 | 0.10 |
Inhalation corticosteroids (CS) | 66(89%) | 11 (69%) | 0.05 |
Pretreatment systemic CS | 35(47%) | 7 (44%) | 0.80 |
Exacerbations last 2 years | 3.7±3.8 | 2.5±2.4 | 0.34 |
CRP mg/l | 55.4±68.6 | 39.5±63.2 | 0.17 |
Treatment failure ≤ day 30 | 33 (44.6%) | 6 (37.5%) | 0.60 |
Time to treatment failure(days) | 53.54±79.25 | 55.27±61.33 | 0.19 |
Lenght of Stay (LOS) (days) | 8.69±6.00 | 6.00±2.28 | 0.03 |
Mortality | 4 (5.4%) | 1(6.3%) | 0.46 |